FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is a composition comprising (i) one or more of the following substances: uridine and cytidine or salts thereof, phosphates, acyl derivatives or esters; and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPC) or esters thereof, iii) choline or salts thereof or esters, iv) at least two vitamins B, for use in preserving or improving functional synaptic connectivity and/or preserving brain network organization in a subject in need thereof.
EFFECT: compositions are used to improve or preserve the brain functional connectivity and/or network organization in a subject.
9 cl, 4 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING POLYUNSATURATED FATTY ACIDS (PUFA), AND METHODS OF APPLICATION THEREOF | 2006 |
|
RU2436571C2 |
| NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
| IMPROVEMENT OF MEMORY IN PATIENTS WITH 24-26 POINTS BY MENTAL STATE MINI-EXAMINATION | 2008 |
|
RU2529815C2 |
| IMPROVEMENT OF MEMORY IN PATIENTS WITH ESTIMATION OF 24-26 POINTS OF MINIMAL MENTAL STATE EXAMINATION | 2014 |
|
RU2677345C2 |
| METHOD FOR CONTROL FUNCTIONS IMPROVEMENT | 2012 |
|
RU2637089C2 |
| RECOGNITION IMPROVEMENT | 2012 |
|
RU2638809C2 |
| FOOD COMPOSITION FOR PATIENTS SUFFERING FROM PRODROMAL DEMENTIA | 2008 |
|
RU2487557C2 |
| LIQUID PRODUCT CONTAINING NUCLEOTIDES/NUCLEOSIDES | 2008 |
|
RU2446807C2 |
| THERAPEUTIC COMBINATIONS OF FATTY ACIDS | 2001 |
|
RU2276975C2 |
| ETHYLEICOSAPENTAENOIC ACID OF HIGH PURITY DEGREE AND OTHER DERIVATIVES OF EICOSAPENTAENOIC ACID FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2000 |
|
RU2260423C2 |
